Fundraising Fox

Dr David Llewellyn

Investor

Investment Committee at Tin Alley Ventures

Sydney, New South Wales, Australia

About

David Llewellyn is the co-founder and former CEO of DJS Antibodies, a company built around a proprietary antibody discovery technology. He has over a decade of experience in evolutionary immunology, antibody characterisation, and myeloid cell biology. He holds a PhD in Clinical Medicine from Oxford, which he completed as a Rhodes Scholar, and co-founded Beyond Equality, an organisation focused on gender equality.

Invests in

Biotech

Experience

  1. Sortera BioChairpersoncurrent2025 β€” present
  2. Proxima BioChairpersoncurrent2024 β€” present
  3. The Oxford TrustTrustee2025 β€” 2026
  4. Beyond EqualityTrustee2020 β€” 2025
  5. Beyond EqualityDirector2013 β€” 2020
  6. Beyond EqualityCEO2013 β€” 2016Oxford, England, United Kingdom
  7. DJS AntibodiesManaging Director2022 β€” 2023Oxford, England, United Kingdom
  8. DJS AntibodiesCEO & Co Founder2015 β€” 2022Oxford, England, United Kingdom
  9. University of OxfordPostdoctoral Scientist2014Oxford, England, United Kingdom
  10. Merton College, OxfordDeputy Principal of Postmasters2012 β€” 2014

Education

  1. University of OxfordDoctor of Philosophy (PhD), Clinical Medicine2010 β€” 2014
  2. University of SydneyBachelor of Science (Advanced) (Honours), Biological Sciences2006 β€” 2009

Same school

Shared employers

Colleagues at Tin Alley Ventures